Clinical Trial Update: An Open Label Placebo Study to Assess the Inhalation Profile in Asthmatic Patients Using the Nexthaler® Dry Powder Inhaler (DPI) Device [Phase 2]

View source ↗

Summary

Phase 2 open-label trial assessing the inhalation profile of the Nexthaler Dry Powder Inhaler in asthmatic patients using a placebo formulation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Nexthaler Dry Powder Inhaler

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Asthma | Phase 2 | Status: COMPLETED